List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 122 studies with search of:   "Thiotepa"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
Conditions: Central Nervous System Tumors;   Tumors
Intervention: Drug: thiotepa melphalan
2 Active, not recruiting Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: thiotepa;   Procedure: adjuvant therapy;   Procedure: radiation therapy
3 Completed Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Condition: Lymphoma
Interventions: Drug: leucovorin calcium;   Drug: methotrexate;   Drug: thiotepa
4 Active, not recruiting High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Retinoblastoma;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: filgrastim;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
5 Completed Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cyclophosphamide;   Drug: filgrastim;   Drug: sargramostim;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
6 Active, not recruiting Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: fludarabine phosphate;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
7 Active, not recruiting Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
Condition: Ovarian Cancer
Interventions: Drug: filgrastim;   Drug: melphalan;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation
8 Recruiting Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Conditions: Graft Versus Host Disease;   Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: muromonab-CD3;   Drug: thiotepa;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: flow cytometry;   Procedure: gene expression analysis;   Procedure: immunologic technique;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: natural killer cell therapy;   Procedure: total-body irradiation
9 Recruiting Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: busulfan;   Drug: filgrastim;   Drug: melphalan;   Drug: thiotepa;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
10 Recruiting Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
Condition: Sarcoma
Interventions: Drug: busulfan;   Drug: melphalan;   Drug: thiotepa;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: graft versus host disease prophylaxis/therapy;   Procedure: peripheral blood stem cell transplantation
11 Recruiting Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Conditions: Graft Versus Host Disease;   Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: clofarabine;   Drug: filgrastim;   Drug: melphalan;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Drug: thiotepa;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
12 Recruiting Double Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Neuroblastoma;   Immunodeficiencies;   Anemia
Interventions: Drug: TBI, Thiotepa, Cyclophosphamide, ATG;   Drug: Busulfan, Melphalan, Rabbit ATG;   Drug: Busulfan, Fludarabine, Alemtuzumab;   Drug: Busulfan, Fludarabine, Rabbit ATG;   Drug: Fludarabine, Cyclophosphamide, ATG;   Drug: Busulfan, Cyclosphosphamide, Rabbit ATG,
13 Recruiting Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors
Condition: Brain Tumors
Intervention: Drug: temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
14 Recruiting Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
Conditions: CNS Cancer;   CNS BRAIN
Intervention: Drug: temozolomide followed by high dose busulfan and thiotepa
15 Recruiting Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Conditions: Recurrent Brain Tumors;   Supratentorial PNETs;   Medulloblastomas;   Ependymomas
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: temozolomide;   Drug: thiotepa, carboplatin, etoposide;   Drug: temozolomide, thiotepa;   Procedure: autologous stem cell transplantation;   Drug: etoposide;   Drug: trofosfamid/etoposide
16 Active, not recruiting Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
Condition: Breast Cancer
Interventions: Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: melphalan;   Drug: paclitaxel;   Drug: sargramostim;   Drug: tamoxifen citrate;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
17 Recruiting Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Kidney Cancer;   Liver Cancer;   Retinoblastoma;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Drug: melphalan;   Drug: sargramostim;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: intensity-modulated radiation therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: pharmacological study;   Procedure: positron emission tomography;   Procedure: tomotherapy;   Procedure: total marrow irradiation
18 Recruiting Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Newly-Diagnosed Primary CNS Lymphoma
Conditions: CNS Lymphoma;   CNS Brain Cancer;   Non-Hodgkin's Lymphoma
Intervention: Other: Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
19 Completed Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cyclophosphamide;   Drug: filgrastim;   Drug: melphalan;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
20 Active, not recruiting High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: amifostine trihydrate;   Drug: cyclophosphamide;   Drug: mitoxantrone hydrochloride;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services